PEAIGTMASep 16, 2024

ADIOS: Antibody Development via Opponent Shaping

arXiv:2409.10588v81 citationsh-index: 22Has Code
Originality Incremental advance
AI Analysis

This addresses the challenge of developing long-lived therapies for viruses and other adaptive opponents like antimicrobial resistance, though it is an incremental advance in applying opponent shaping to biological domains.

The paper tackles the problem of designing antibody therapies that account for viral evolution by introducing ADIOS, a meta-learning framework that shapes viral variants to be weaker, outperforming myopic antibodies in targeting current and future strains.

Anti-viral therapies are typically designed to target only the current strains of a virus, a myopic response. However, therapy-induced selective pressures drive the emergence of new viral strains, against which the original myopic therapies are no longer effective. This evolutionary response presents an opportunity: our therapies could both defend against and actively influence viral evolution. This motivates our method ADIOS: Antibody Development vIa Opponent Shaping. ADIOS is a meta-learning framework where the process of antibody therapy design, the outer loop, accounts for the virus's adaptive response, the inner loop. With ADIOS, antibodies are not only robust against potential future variants, they also influence, i.e., shape, which future variants emerge. In line with the opponent shaping literature, we refer to our optimised antibodies as shapers. To demonstrate the value of ADIOS, we build a viral evolution simulator using the Absolut! framework, in which shapers successfully target both current and future viral variants, outperforming myopic antibodies. Furthermore, we show that shapers modify the distribution over viral evolutionary trajectories to result in weaker variants. We believe that our ADIOS paradigm will facilitate the discovery of long-lived vaccines and antibody therapies while also generalising to other domains. Specifically, domains such as antimicrobial resistance, cancer treatment, and others with evolutionarily adaptive opponents. Our code is available at https://github.com/olakalisz/adios.

Code Implementations2 repos
Foundations

The foundational work for this paper's niche, ranked by how specifically the neighbourhood builds on it — not by global fame.

Your Notes